Intracoronary optical coherence tomography and the evaluation of stents

Expert Review of Medical Devices

Volumn 6, Issue 2, 2009, Pages 157-167

  Barlis, Peter ^a   van Soest, Gijs ^a   Regar, Evelyn ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Coronary circulation; Optical coherence tomography; Optical frequency domain imaging; Stent

Indexed keywords

ACUTE CORONARY SYNDROME; ARTERIAL WALL THICKNESS; ARTERY CATHETERIZATION; ARTIFACT; BALLOON OCCLUSION; CORONARY STENT; EQUIPMENT DESIGN; HEART VENTRICLE FIBRILLATION; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGING SYSTEM; INTRAVASCULAR ULTRASOUND; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL RESOLUTION; PRODUCT DEVELOPMENT; REVIEW; SAFETY; THREE DIMENSIONAL IMAGING; CORONARY BLOOD VESSEL; EVALUATION; HEART CATHETERIZATION; HISTOLOGY; STENT;

CORONARY VESSELS; EVALUATION STUDIES AS TOPIC; HEART CATHETERIZATION; HUMANS; STENTS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 67449103336     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.6.2.157     Document Type: Review

References (78)

1. Van Beusekom HM, Regar E, Peters I, Van der Giessen WJ. Long-term effects of endovascular radiation after balloon angioplasty: assessment by OCT and histology. In: Optical Coherence Tomography in Cardiovascular Research. Regar E, van Leeuwen AMGJ, Serruys PW (Eds). Informa Healthcare, London, UK (2007)
2. Tearney GJ, Yabushita H, Houser SL et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 107(1), 113-119 (2003).
3. Regar E, Schaar JA, Mont E, Virmani R, Serruys PW. Optical coherence tomography. Cardiovasc. Radiat. Med. 4(4), 198-204 (2003).
4. Jang IK, Tearney GJ, MacNeill B et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 111(12), 1551-1555 (2005).
5. Tearney GJ, Jang IK, Bouma BE. Optical coherence tomography for imaging the vulnerable plaque. J. Biomed. Opt. 11(2), 021002 (2006).
6. Shite J, Matsumoto D, Yokoyama M. Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography. Eur. Heart J. 27(12), 1389 (2006).
7. Tanigawa J, Barlis P, Di Mario C. Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention 3, 128-136 (2007).
8. Tanigawa J, Barlis P, Di Mario C. Do unapposed stent struts endothelialise? In vivo demonstration with optical coherence tomography. Heart 93(3), 378 (2007).
9. Prati F, Zimarino M, Stabile E et al. Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, on a rabbit carotid model. Heart 94, 217-221 (2008).
10. Takano M, Inami S, Jang IK et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am. J. Cardiol. 99(8), 1033-1038 (2007).
11. Tanigawa J, Barlis P, Dimopoulos K, Di Mario C. Optical coherence tomography to assess malapposition in overlapping drug-eluting stents. EuroIntervention 3(13), 580-583 (2008).
12. Barlis P, Serruys PW, DeVries A, Regar E. Optical coherence tomography assessment of vulnerable plaque rupture: predilection for the plaque 'shoulder'. Eur. Heart J. 29(16), 2023 (2008).
13. Barlis P, Serruys PW, Gonzalo N, van der Giessen WJ, de Jaegere PJ, Regar E. Assessment of culprit and remote coronary narrowings using optical coherence tomography with long-term outcomes. Am. J. Cardiol. 102(4), 391-395 (2008).
14. Finn AV, Joner M, Nakazawa G et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115(18), 2435-2441 (2007).
15. Michelson AA, Morley EW. On the relative motion of the earth and the luminiferous aether. Am. J. Sci. S5(151), 449-463 (1887).
16. Schmitt JM, Knuttel A, Yadlowsky M, Eckhaus MA. Optical-coherence tomography of a dense tissue: statistics of attenuation and backscattering. Phys. Med. Biol. 39(10), 1705-1720 (1994).
17. Schmitt JM. Optical coherence tomography (OCT): a review. IEEE J. Sel. Top. Quant. Elec. 5(4), 1205-1215 (1999).
18. Bouma BE, Tearney GJ. Power-efficient nonreciprocal interferometer and linear-scanning fiber-optic catheter for optical coherence tomography. Opt. Lett. 24(8), 531-533 (1999).
19. Prati F, Cera M, Ramazzotti V et al. From bench to bedside. Circ. J. 72(5), 839-843 (2008).
20. Tanigawa J, Barlis P, Kaplan S, Goktekin O, Di Mario C. Stent strut apposition in complex lesions using optical coherence tomography. Am. J. Cardiol. 98(8), M97 (2006).
21. Takano M, Yamamoto M, Inami S et al. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist? J. Am. Coll. Cardiol. 51(9), 968-969 (2008).
22. Prati F, Cera M, Ramazzotti V, Imola F, Giudice R, Albertucci M. Safety and feasibility of a new non-occlusive technique for facilitated intracoronary optical coherence tomography (OCT) acquisition in various clinical and anatomical scenarios. EuroIntervention 3(11), 365-370 (2007).
23. Matsumoto D, Shite J, Shinke T et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur. Heart J. 28(8), 961-967 (2007).
24. Chen BX, Ma FY, Wei L et al. Neointimal coverage of bare metal and sirolimus-eluting stents evaluated with optical coherence tomography. Heart 94, 566-570 (2008).
25. Kubo T, Imanishi T, Takarada S et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J. Am. Coll. Cardiol. 50(10), 933-939 (2007).
26. Tanigawa J, Barlis P, Di Mario C. Heavily calcified coronary lesions preclude strut apposition despite high pressure balloon dilatation and rotational atherectomy: in-vivo demonstration with optical coherence tomography. Circ. J. 72(1), 157-160 (2008).
27. Yamaguchi T, Terashima M, Akasaka T et al. Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. Am. J. Cardiol. 101(5), 562-567 (2008).
28. Kim JS, Choi EY, Choi D, Jang Y. Images in cardiovascular medicine. Catastrophic thrombus formation during optical coherence tomography. Circulation 118(6), E101-E102 (2008).
29. Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS Jr, King SB 3rd, Gruentzig AR. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 72(5), 1044-1052 (1985).
30. Dorros G, Cowley MJ, Simpson J et al. Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation 67(4), 723-730 (1983).
31. Davis K, Kennedy JW, Kemp HG Jr, Judkins MP, Gosselin AJ, Killip T. Complications of coronary arteriography from the Collaborative Study of Coronary Artery Surgery (CASS). Circulation 59(6), 1105-1112 (1979).
32. Nishimura RA, Holmes DR Jr, McFarland TM, Smith HC, Bove AA. Ventricular arrhythmias during coronary angiography in patients with angina pectoris or chest pain syndromes. Am. J. Cardiol. 53(11), 1496-1499 (1984).
33. Goldstein JA, Butterfield MC, Ohnishi Y, Shelton TJ, Corr PB. Arrhythmogenic in?uence of intracoronary thrombosis during acute myocardial ischemia. Circulation 90(1), 139-147 (1994).
34. Gorenek B. Tachyarrhythmias in percutaneous coronary interventions. J. Electrocardiol. 39(4), E411-E415 (2006).
35. Huang JL, Ting CT, Chen YT, Chen SA. Mechanisms of ventricular fibrillation during coronary angioplasty: increased incidence for the small orifice caliber of the right coronary artery. Int. J. Cardiol. 82(3), 221-228 (2002).
36. Missri J, Jeresaty RM. Ventricular fibrillation during coronary angiography: reduced incidence with nonionic contrast media. Cathet. Cardiovasc. Diagn. 19(1), 4-7 (1990).
37. Pedersen HK, Jacobsen EA, Mortensen E, Refsum H. Contrast-medium-induced ventricular fibrillation: arrhythmogenic mechanisms and the role of antiarrhythmic drugs in dogs. Acad. Radiol. 2(12), 1082-1088 (1995).
38. Quigley PJ, Maurer BJ. Ventricular fibrillation during coronary angiography: association with potassium-containing glyceryl trinitrate. Am. J. Cardiol. 56(1), 191 (1985).
39. Rudoff J, Phillips L. High-osmolality and low-osmolality contrast agents. N. Engl. J. Med. 327(3), 203-204 (1992).
40. +/l. Acta Radiol. 30(2), 207-212 (1989).
41. Hayakawa K, Yamashita K. Low-osmolality contrast media-induced ventricular fibrillation. Invest. Radiol. 24(4), 298-301 (1989).
42. Morris TW, Ventura J. Incidence of fibrillation with dilute contrast media for intra-arterial coronary digital subtraction angiography. Invest. Radiol. 21(5), 416-418 (1986).
43. Chai CM, Karlsson JO, Almen T. Incidence of ventricular fibrillation during left coronary arteriography in pigs: comparison of a solution of the nonionic dimer iodixanol with solutions of five different nonionic monomers. Acta Radiol. 49(2), 150-156 (2008).
44. Albiero R, Rau T, Schluter M et al. Comparison of immediate and intermediate-term results of intravascular ultrasound versus angiography-guided Palmaz-Schatz stent implantation in matched lesions. Circulation 96(9), 2997-3005 (1997).
45. Schiele F, Meneveau N, Seronde MF, Deforet MF, Gupta S, Bassand JP. Predictors of event-free survival after repeat intracoronary procedure for in-stent restenosis; study with angiographic and intravascular ultrasound imaging. Eur. Heart J. 21(9), 754-762 (2000).
46. Iakovou I, Mintz GS, Dangas G et al. Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries. Am. J. Cardiol. 92(10), 1171-1176 (2003).
47. Cheneau E, Satler LF, Escolar E et al. Underexpansion of sirolimus-eluting stents: incidence and relationship to delivery pressure. Catheter Cardiovasc. Interv. 65(2), 222-226 (2005).
48. Fujii K, Mintz GS, Kobayashi Y et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 109(9), 1085-1088 (2004).
49. Barlis P, Tanigawa J, Di Mario C. Coronary bioabsorbable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings. Eur. Heart J. 28(19), 2319 (2007).
50. Hong MK, Mintz GS, Lee CW et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113(3), 414-419 (2006).
51. Tanabe K, Serruys PW, Degertekin M et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 111(7), 900-905 (2005).
52. Tanigawa J, Barlis P, Dimopoulos K, Dalby M, Moore P, Di Mario C. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. Int. J. Cardiol. DOI:10.1016/j.ijcard.2008.05.069 (2008) (Epub ahead of print).
53. Regar E, Schaar J, Serruys PW. Images in cardiology. Acute recoil in sirolimus eluting stent: real time, in vivo assessment with optical coherence tomography. Heart 92(1), 123 (2006).
54. Tanimoto S, Rodriguez-Granillo G, Barlis P et al. A novel approach for quantitative analysis of intracoronary optical coherence tomography: high inter-observer agreement with computer-assisted contour detection. Catheter Cardiovasc. Interv. 72(2), 228-235 (2008).
55. Finn AV, Nakazawa G, Joner M et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler. Thromb. Vasc. Biol. 27(7), 1500-1510 (2007).
56. Joner M, Finn AV, Farb A et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 48(1), 193-202 (2006).
57. Lee SH, Park JS, Shin DG et al. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am. J. Cardiol. 100(4), 627-630 (2007).
58. Barlis P, Sianos G, Ferrante G, Del Furia F, D'Souza S, Di Mario C. The use of intra-coronary optical coherence tomography for the assessment of sirolimus-eluting stent fracture. Int. J. Cardiol. DOI: 10.1016/ j.ijcard.2008.04.076 (2008) (Epub ahead of print).
59. Surmely J, Takeda Y, Ita T, Suzuki T. Acute optical coherence tomography findings after stenting. In: Optical Coherence Tomography in Cardiovascular Research. Regar E, van Leeuwen AMGJ, Serruys PW (Eds). Informa Healthcare, London, UK (2007).
60. Tanimoto T, Aoki J, Serruys PW, Regar E. Paclitaxel-eluting stent restenosis shows three-layer appearance by optical coherence tomography. EuroIntervention 1(4), 484 (2006).
61. Regar E, van Beusekom HM, van der Giessen WJ, Serruys PW. Images in cardiovascular medicine. Optical coherence tomography findings at 5-year follow-up after coronary stent implantation. Circulation 112(23), E345-E346 (2005).
62. Bouma BE, Tearney GJ, Yabushita H et al. Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart 89(3), 317-320 (2003).
63. van Beusekom HM, Whelan DM, Hofma SH et al. Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J. Am. Coll. Cardiol. 32(4), 1109-1117 (1998).
64. Barlis P, Di Mario C, Van Beusekom HM, Gonzalo N, Regar E. Novelties in cardiac imaging: Optical coherence tomography. EuroIntervention 4(Suppl. C), C22-C26 (2008).
65. van Busker HM, Saia F, Zindler JD et al. Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus. Eur. Heart J. 28(8), 974-979 (2007).
66. Bonnema GT, Cardinal KO, McNally JB, Williams SK, Barton JK. Assessment of blood vessel mimics with optical coherence tomography. J. Biomed. Opt. 12(2), 024018 (2007).
67. Yun SH, Tearney GJ, de Boer JF, Iftimia N, Bouma B. High-speed optical frequency-domain imaging. Opt. Express 11(22), 2953-2963 (2003).
68. Fercher AF, Hitzenberger CK, Kamp G, Elzaiat SY. Measurement of intraocular distances by backscattering spectral interferometry. Opt. Commun. 117(1-2), 43-48 (1995).
69. Chinn SR, Swanson EA, Fujimoto JG. Optical coherence tomography using a frequency-tunable optical source. Opt. Lett. 22(5), 340-342 (1997).
70. Rollins AM, Kulkarni MD, Yazdanfar S, Ung-arunyawee R, Izatt JA. In vivo video rate optical coherence tomography. Opt. Express 3(6), 219-229 (1998).
71. Leitgeb R, Hitzenberger CK, Fercher AF. Performance of Fourier domain vs. time domain optical coherence tomography. Opt. Express 11(8), 889-894 (2003).
72. Choma M, Sarunic M, Yang C, Izatt J. Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt. Express 11(18), 2183-2189 (2003).
73. de Boer JF, Cense B, Park BH, Pierce MC, Tearney GJ, Bouma BE. Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt. Lett. 28(21), 2067-2069 (2003).
74. Yun SH, Tearney GJ, Vakoc BJ et al. Comprehensive volumetric optical microscopy in vivo. Nat. Med. 12(12), 1429-1433 (2006).
75. Huber R, Adler DC, Fujimoto JG. Buffered Fourier domain mode locking: unidirectional swept laser sources for optical coherence tomography imaging at 370,000 lines/s. Opt. Lett. 31(20), 2975-2977 (2006).
76. Moon S, Kim DY. Ultra-high-speed optical coherence tomography with a stretched pulse supercontinuum source. Opt. Express 14, 11575-11584 (2006).
77. Lim H, Mujat M, Kerbage C et al. High-speed imaging of human retina in vivo with swept-source optical coherence tomography. Opt. Express 14(26), 12902-12908 (2006).
78. Tearney G, Waxman S, Shishkov M et al. Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. J. Am. Coll. Cardiol. Img 1, 752-761 (2008).